Skip to content


Online 20.5.2022

Taiwan-Finland Precision Health Seminar

Time: 9:30 - 11:00 EEST at Webex platform.

The organizers will send the meeting link to participants before the event.


Further information

Mr. Hung-Yi CHANG
Advisor, Business Finland
hung-yi.chang (at)

Business Finland Taiwan and the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) co-organize the ‘’Taiwan-Finland Precision Health Seminar’’ to invite companies from both sides to present their solutions and build networks. The purpose of the event is to create a platform to facilitate the development for precision health through international collaborations between Finland and Taiwan.


14:30 Introduction
Mr. Jere Tala, Senior Advisor, Business Finland

14:35 Finnish Leadership and Solutions in Precision Health
Dr. Päivi Sillanaukee, Ambassador for Health and Wellbeing, Ministry for Foreign Affairs of Finland

14:45 The Competitiveness of Multi-Sectors Integration Driving Precision
Health Development in Taiwan
Chung-Hsiun Herbert Wu, Director of Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), Ministry of Economic Affairs, TW.

14:55 1 Cell, 2 Week, 3D Culture to Save Lives: Precision Cancer Treatment with 3D Cell Culture
Ms.Ying-Chih Chang, Founder, Acrocyte Therapeutics Inc.

15:05 Revolutionizing Drug Development and Personalizing Care: BC Platforms
Mr. Nino Da Silva, Deputy Managing Director, BC Platforms

15:15 Population Genomics and Precision Health: A Taiwan Perspective
Mr. Shih-Feng (Peter) TSAI
Distinguished Investigator, NHRI
Chair Professor, National Yang Ming Chiao Tung University
Founding Board Director, TGIA, Inc.

15:25 Pharmacogenetics - Precision Medicine for Your Patients Today
Mr. Valter Rönnholm, CEO, Abomics Oy

15:35 The Application of Precision Medicine for Cardiovascular Care in
NCKUH, Taiwan
Mr. Ping-Yen Liu, Director, Clinical Medicine Research Center, National
Cheng Kung University Hospital

15:45 BCB Medical – the Nordic Market Leader in Gathering and Analyzing Clinical Data
Ms. Lisse-Lotte Hermansson, CSO, Chief Scientific Officer, BCB Medical Ltd.

15:55  Q&A, Closing

Read more from the event page and register.